Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services
Childhood Pneumonia, Hypoxemia
About this trial
This is an interventional health services research trial for Childhood Pneumonia focused on measuring IMCI services, Pulse Oximeter, Acute respiratory infections, Implementation research, Hypoxaemia, Childhood Pneumonia, Resource poor settings
Eligibility Criteria
Inclusion Criteria:
- Sick children aged 2 to 59 months
- Presenting with cough or difficult breathing
- Receiving IMCI services in the selected facilities will be enrolled
Exclusion Criteria:
- Severely ill children who need to be referred immediately
- If the parents of the children are unwilling to participate
Sites / Locations
- International Centre for Diarrhoeal Disease Research, BangladeshRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention (Pulse Oximeter)
Comparison
The intervention facilities will provide IMCI services with PO in addition to following existing IMCI guidelines. The IMCI service providers will classify and treat children presenting with cough and difficult breathing based on history and clinical signs. In addition, they will use PO to measure the SpO2 status of the sick children. Children clinically classified as 'Pneumonia' but having SpO2<90% will be referred to higher-level facilities for in-patient management. Only the children clinically classified 'Pneumonia' and having SpO2>90% will be treated through home-based management with oral antibiotics (amoxicillin, twice daily for five day).
The comparison facilities will continue providing routine IMCI services as per the existing guidelines. In routine IMCI services, IMCI service providers classify and treat children presenting with cough and difficult breathing based on history and clinical signs only. In routine IMCI services in Bangladesh, PO has not been introduced. Therefore, in the comparison facilities all children clinically classified as 'Pneumonia' will be treated through home-based management with oral antibiotics (amoxicillin, twice daily for five day)